chlorambucil has been researched along with Fibrosis, Inflammatory Perianeurysmal in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hollingworth, P | 1 |
Denman, AM | 1 |
Gumpel, JM | 1 |
Moroni, G | 1 |
Faricciotti, A | 1 |
Farricciotti, A | 1 |
Cappelletti, M | 1 |
Ponticelli, C | 1 |
2 other studies available for chlorambucil and Fibrosis, Inflammatory Perianeurysmal
Article | Year |
---|---|
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression.
Topics: Chlorambucil; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Middle Aged; Polya | 1980 |
Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
Topics: Anti-Inflammatory Agents; Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; H | 1999 |